Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
The largest wildfire in at least 50 years in France, which claimed one life, has now been brought under control. The fire swept through 17,000 hectare...
Read More
A yellow heatwave warning remains in place today. Hazy sunshine with a gentle coastal breeze. Daytime are forecast to reach between 30 and 32°C in the...
Read More
A major pile-up involving around ten vehicles, including a truck and a motorcycle, occurred early on the 7th of August in the Las Planas tunnel on the...
Read More
Banque Havilland (Monaco) SAM will relaunch as Moncrief Private Bank (Monaco) SAM in late 2025, following its acquisition by an international investor...
Read More
Monaco has introduced a new road safety law that bans children under 14 from using electric scooters or electric bikes on public roads. The change is ...
Read More
